|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| General and administration expenses | |||||
| Consulting and management fees | |||||
| General and administrative | |||||
| Marketing and donations | |||||
| Finance cost | |||||
| Professional fees | |||||
| Share-based payment expense | |||||
| Total expense | |||||
| Other (expenses) income, net | |||||
| Foreign exchange gain (loss) | |||||
| Accretion expense on convertible debt | |||||
| Accretion on joint venture settlement obligation | |||||
| Interest expense and bank charges | |||||
| Unrealized gain(loss) and foreign exchange on marketable securities | |||||
| Loss on modification of joint venture settlement obligation | |||||
| Share of loss on investment in associate | |||||
| Gain on settlement of loans receivable | |||||
| Gain on settlement of accounts payable and accrued liabilities | |||||
| Interest income | |||||
| Loss on disposition of shares | |||||
| Loss on shares for debt settlement | |||||
| Loss on share settlement of joint venture settlement obligation | |||||
| Fair value adjustment on option liability | |||||
| Other income | |||||
| Transaction costs expensed on convertible debentures | |||||
| Fair value adjustment on derivative liability | |||||
| Loss | |||||
| Other comprehensive income (loss | |||||
| Cumulative translation adjustment income (loss) | |||||
| Total comprehensive loss | |||||
| Loss per share-basic | |||||
| Loss per share-diluted | |||||
| Weighted average shares outstanding-basic | |||||
| Weighted average shares outstanding-diluted | |||||
Loading...
